Atlas Trials

Reduction of Plasma Free VEGF-A Using Low-dose Bevacizumab in Hemodialysis Patients

Clinical trial NCT02695641 · WITHDRAWN

Trial details

NCT number
NCT02695641
Sponsor
Mayo Clinic
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
End Stage Renal DiseaseHemodialysis Vascular Access Failure
Start date
2019-08-01
Primary completion
2020-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.